Grayson: Kucer's the Use of Antibiotics 2 Volume Set






Kucers' The Use of Antibiotics is the leading major reference work in this vast and rapidly developing field. More than doubled in length compared to the fifth edition, the sixth edition comprises 3000 pages over 2-volumes in order to cover all new and existing therapies, and emerging drugs not yet fully licensed.

Concentrating on the treatment of infectious diseases, the content is divided into 4 sections: antibiotics, anti-fungal drugs, anti-parasitic drugs and anti-viral drugs, and is highly structured for ease of reference.Within each section, each chapter is structured to cover susceptibility, formulations and dosing (adult and paediatric), pharmacokinetics and pharmacodynamics, toxicity and drug distribution, detailed discussion regarding clinical uses, a feature unique to this title.

Compiled by an expanded team of internationally renowned and respected editors, with a vast number of contributors spanning Europe, Africa, Asia, Australia, South America, the US and Canada, the sixth edition adopts a truly global approach. It will remain invaluable for anyone using antimicrobial agents in their clinical practice and provides in a systematic and concise manner all the information required when treating infections requiring antimicrobial therapy.


Key Features
  • The essential reference to this vast, and rapidly developing field.
  • Highly structured for ease of reference.
  • Covers more than 350 individal antimicrobial agents, more than twice as many as the preceding edition.
  • International team of highly respected authors and editors ensures a truly global approach.

Now Kucers' The Use of Antibiotics is available free to purchasers of the books as an electronic version on line or on your desktop:
  • It provides access to the entire 2-volume print material
  • It is fully searchable, so you can find the relevant information you need quickly
  • Live references are linked to PubMed referring you to the latest journal material
  • Customise the contents - you can highlight sections and make notes
  • Comments can be shared with colleagues/tutors for discussion, teaching and learning
  • The text can also be reflowed for ease of reading
  • Text and illustrations copied will be automatically referenced to Kucers' The Use of Antibiotics


About the Author
  • M Lindsay Grayson MB BS MD MSC FRACP FRCP FAFPHM Professor of Medicine and Director, Infectious Disease and Microbiology Departments, Austin Health Department of Epidemiology and Preventative Medicine, Monash University Department of Medicine, University of Melbourne, Melbourne, Australia.


Contents 
ANTIBIOTICS
PART 1 - Penicillins and Related Drugs
  • Benzylpenicillin (Penicillin G)
  • Phenoxypenicillins
  • Ampicillin, Amoxicillin and other Ampicillin-like penicillins
  • Methicillin
  • Isoxazolyl penicillins: Oxacillin, cloxacillin, dicloxacillin & flucloxacillin
  • Nafcillin
  • Carbenicillin, Carindacillin, Carfecillin & Ticarcillin
  • Mezlocillin, Azlocillin, Apalcillin & Piperacillin
  • Mecillinam (Amdinocillin) & Pivmecillinam
  • Temocillin
  • Beta-lactamase inhibitors and combinations:
  • Clavulanic Acid
  • Sulbactam
  • Tazobactam and Brobactam
  • Co-amoxiclav (amoxycillin-clavulanic acid)
  • Ampicillin-sulbactam
  • Ticarcillin-clavulanic acid
  • Piperacillin-tazobactam
PART 2 - Cephalosporins and Related Drugs
  • Cephalothin and Cefazolin
  • Cephalexin
  • Cephadroxil, Cephaloridine, Cephacetrile, Cephapirin, Cephradine and other rarely used first-generation cephalosporins
  • Cefaclor, cefprozil and loracarbef
  • Cefuroxime
  • Cefotiam, Cefuzonam, Cefamandole, Cefonicid and Ceforanide
  • Cefoxitin, cefotetan and other cephamycins (cefmetazole and flomoxef)
  • Cefoperazone and cefoperazone-sulbactam
  • Cefotaxime
  • Ceftriaxone
  • Ceftizoxime, cefdinir, cefditoren, cefpodoxime, ceftibuten, cefsulodin and cefpiramide
  • Cefixime
  • Ceftazidime
  • Cefpirome
  • Cefepime
  • Ceftaroline
  • Ceftobiprole
  • Aztreonam
PART 3 – Carbapenems
  • Imipenem
  • Meropenem
  • Doripenem
  • Ertapenem
  • Biapenem
  • Faropenem
  • Panipenem
  • Ritapenem
  • Sulopenem
PART 4 - Glycopeptides and Lipopeptides
  • Vancomycin
  • Teicoplanin
  • Daptomycin
  • Oritavancin
  • Dalbavancin
  • Telavancin
  • Ramoplanin
PART 5 - Aminoglycosides
  • Kanamycin
  • Gentamicin
  • Tobramycin
  • Amikacin
  • Sisomicin and Netilmicin
  • Isepamicin
  • Neomycin
PART 6 – Macrolides and Ketolides
  • Erythromycin
  • Roxithromycin
  • Clarithromycin
  • Azithromycin
  • Josamycin and Rosaramicin
  • Telithromycin
  • Cethromycin
PART 7 – Tetracyclines and related drugs
  • Tetracycline
  • Doxycycline
  • Minocycline
  • Tigecycline
PART 8 – Other antibiotics
  • Linezolid
  • Quinupristin-dalfopristin
  • Pristinamycin
  • Fosfomycin
  • Fusidic acid (Fusidate sodium)
  • Polymyxins and Colistin
  • Novobiocin
  • Bacitracin and Gramicidin
  • Mupirocin
  • Clindamycin and Lincomycin
  • Chloramphenicol and Thiamphenicol
  • Spectinomycin
PART 9 – Anti-folate agents and other synthetic antibacterials
  • Sulfonamides
  • Trimethoprim, Co-trimoxazole (Co-T) & related agents
  • Pyrimethamine
  • Dapsone
  • Trimetrexate
  • Iclaprim
  • Nitrofurans: Nitrofurazone, Furazolidone & Nitrofurantoin
  • Methenamine Mandelate & Methenamine Hippurate
PART 10 – Nitroimidazoles
  • Metronidazole
  • Tinidazole
PART 11 – Quinolones and fluoroquinolones
  • Nalidixic Acid & Other Older Quinolones
  • Ciprofloxacin
  • Norfloxacin
  • Ofloxacin
  • Levofloxacin
  • Moxifloxacin
  • Gatifloxacin
  • Garenoxacin
  • Gemifloxacin
  • Sitafloxacin
  • Enoxacin
  • Pefloxacin
  • Sparfloxacin
  • Lomefloxacin
  • Rufloxacin
  • Tosufloxacin
  • Fleroxacin
  • Newer, discontinued fluoroquinolones: Temafloxacin, Trovafloxacin, Grepafloxacin and Clinafloxacin
PART 12 – Anti-Tuberculous Drugs
  • Isoniazid
  • Ethambutol
  • Pyrazinamide
  • Rifampicin (Rifampin)
  • Rifabutin
  • Rifaximin
  • Rifapentine
  • Streptomycin
  • Para-aminosalicylic Acid (PAS)
  • Ethionamide and prothionamide
  • Thiacetazone
  • Capreomycin
  • Cycloserine
  • Viomycin

ANTI-FUNGAL DRUGS
PART 1 - Polyenes
  • Amphotericin B (AMB): Deoxycholate & Lipid Formulations
  • Nystatin
  • Natamycin (Pimaricin)
PART 2 – Echinocandins, Allylamines and Benzylamine derivatives
  • Echinocandins – Caspofungin, Anidulafungin & Micafungin
  • Terbinafine
  • Butenafine
  • Naftifine
PART 3 – Systemic Azoles
  • Ketoconazole
  • Fluconazole
  • Itraconazole
  • Miconazole
  • Voriconazole
  • Posaconazole
  • Ravuconazole
  • Albaconazole
  • Isavuconazole
PART 4 – Topical Azoles
  • Bifonazole
  • Butoconazole
  • Clotrimazole
  • Croconazole
  • Eberconazole
  • Econazole
  • Enilconazole
  • Fenticonazole
  • Flutrimazole
  • Isoconazole
  • Lanoconazole
  • Neticonazole
  • Oxiconazole
  • Sertaconazole
  • Sulconazole
  • Terconazole
  • Tioconazole
  • KP-103
PART 5 – Topical agents – Thiocarbamates, Hydroxypyridones and Morpholine
  • Tolnaftate
  • Amorolfine
  • Ciclopirox
  • Rilopirox
PART 6 – Other antifungal agents and new agents in development
  • Flucytosine (5-Fluorocytosine; 5-FC)
  • Griseofulvin
  • Haloprogin
  • New agents in development – Nikkomycin Z, CAY-1, Sodarins, Butenolides, Enfungumab, Inositol phosphoceramide synthase inhibitors

ANTI-PARASITIC DRUGS
PART 1 – Anti-malarial agents
  • Chloroquine
  • Amodiaquine
  • Quinine and quinidine
  • Mefloquine
  • Halofantrine
  • Lumefantrine
  • Primaquine
  • Piperaquine
  • Tafenoquine
  • Atovaquone
  • Proguanil and chloroproguanil
  • Artemisinins
PART 2 - Agents active against Intestinal and Intra-abdominal Protozoa
  • Iodoquinol and Quinacrine
  • Fumagillin
  • Furazolidone (Furazolidine)
  • Diloxanide furoate
  • Spiramycin
  • Nitazoxanide
  • Paromomycin
PART 3 - Agents active against American Trypanosomiasis
  • Benznidazole
  • Nifurtimox
  • PART 4 - Agents active against African Trypanosomiasis
  • Suramin
  • Melarsoprol
  • Eflornithine
PART 5 – Agents active against leishmania and other pathogens
  • Pentamidine
  • Antimonial agents
  • Miltefosine
PART 6 - Agents active against Helminths
  • Albendazole
  • Mebendazole
  • Thiabendazole
  • Triclabendazole
  • Ivermectin
  • Diethylcarbamazine (DEC)
  • Pyrantel pamoate
  • Praziquantel
  • Oxamniquine
  • Metrifonate
  • Niclosamide
PART 7 - Agents active against Ectoparasites
  • Permethrin
  • Piperonyl butoxide
  • Lindane
  • Malathion
  • Crotamiton

ANTI-VIRAL DRUGS
PART 1 - Agents active against Herpesviruses
  • Aciclovir
  • Valaciclovir
  • Famciclovir & Penciclovir
  • Ganciclovir & Valganciclovir
  • Cidofovir
  • Vidarabine
  • Foscarnet
  • Maribavir
  • Trifluridine (Trifluorothymidine)
  • Idoxuridine
  • Fomivirsen
PART 2 - Agents active against Human Immunodeficiency Virus
2a - Inhibitors of Reverse Transcriptase
  • Zidovudine
  • Didanosine
  • Zalcitabine
  • Lamivudine
  • Stavudine (d4T)
  • Abacavir
  • Emtricitabine
  • Tenofovir
  • Amdoxovir
  • Apricitabine
2b – Non-Nucleoside Reverse Transcriptase inhibitors (NNRTIs)
  • Nevirapine
  • Efavirenz
  • Delavirdine
  • Etravirine
  • Rilpirivine
2c - Inhibitors of HIV Protease
  • Saquinavir
  • Ritonavir
  • Indinavir
  • Nelfinavir
  • Lopinavir
  • Amprenavir and fosamprenavir
  • Darunavir
  • Atazanavir
  • Tipranavir
2d - Other Anti-HIV Agents
  • Enfuvirtide
  • Maraviroc
  • Raltegravir & other HIV integrase inibitors
Part 3 - Agents active against Hepatitis viruses
  • Entecavir
  • Adefovir dipivoxil
  • Telbivudine
  • Torcitabine & Valtorcitabine
  • Clevudine
  • Ribavirin and Viramidine
  • Pegylated Interferon Alfa
  • Protease and polymerase inhibitors for the treatment of hepatitis C virus infection
Part 4 - Agents active against Respiratory viruses
  • Amantadine and Rimantadine
  • Zanamivir and Polymeric Zanamivir Conjugates
  • Oseltamivir
  • Peramivir 


Product Details 
 
  • Hardcover: 3157 pages
  • Publisher: American Society for Microbiology; Har/Psc edition (October 2010)
  • Language: English
  • ISBN-10: 0340927674
  • ISBN-13: 978-0340927670 
     
    List Price: $965.50 
     
     

    Medical Lecture Note Copyright © 2011